On-Q-ity, Inc. to Present at the Molecular Medicine Tri-Conference

WALTHAM, Mass., Feb. 17, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company focused on novel circulating tumor cell (CTC) capture and characterization for clinical researchers and physicians that will enhance decision-making across multiple cancer types, today announced that it will be a corporate sponsor of the Molecular Medicine Tri-Conference being held in San Francisco February 21-23 and will be presenting during the Circulating Tumor Cells Conference Program.